Neda Hashemi‐Sadraei
-
- Bladder and Urothelial Cancer Treatments 4
- Urinary and Genital Oncology Studies 4
- Testicular diseases and treatments 3
-
- Cancer Immunotherapy and Biomarkers 4
-
- Renal cell carcinoma treatment 2
- Metastasis and carcinoma case studies 2
-
- Glioma Diagnosis and Treatment 3
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Nasser H. HannaOlumide B. GbolahanBert H. O’NeilHristos Z. KaimakliotisChia‐Sui KaoRohan GuptaModupe IdowuCarmen M. Perrino
- Journals
- Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (3 papers)Stroke (1 paper)
- Partner nations
- United StatesPeru
In The Last Decade
Neda Hashemi‐Sadraei
22 papers receiving 163 citations
Peers
Comparison fields: 5 of 40
- Surgery 108
- Oncology 59
- Urology 11
- Pulmonary and Respiratory Medicine 47
- Hematology 16
Countries citing papers authored by Neda Hashemi‐Sadraei
This map shows the geographic impact of Neda Hashemi‐Sadraei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neda Hashemi‐Sadraei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neda Hashemi‐Sadraei more than expected).
Fields of papers citing papers by Neda Hashemi‐Sadraei
This network shows the impact of papers produced by Neda Hashemi‐Sadraei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neda Hashemi‐Sadraei. The network helps show where Neda Hashemi‐Sadraei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Neda Hashemi‐Sadraei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 5 | |
| 7 | 2020 | 0 | |
| 8 | Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients | 2019 | 1 |
| 9 | 2019 | 30 | |
| 10 | 2019 | 14 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 13 | |
| 13 | 2017 | 17 | |
| 14 | 2015 | 17 | |
| 15 | 2014 | 3 | |
| 16 | 2014 | 7 | |
| 17 | 2013 | 1 | |
| 18 | 2011 | 1 | |
| 19 | 2011 | 1 | |
| 20 | 2007 | 4 |
About Neda Hashemi‐Sadraei
Neda Hashemi‐Sadraei is a scholar working on Oncology, Transplantation and Genetics, having authored 24 papers that have together received 168 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Urinary and Genital Oncology Studies (4 papers), Testicular diseases and treatments (3 papers), Glioma Diagnosis and Treatment (3 papers), Renal cell carcinoma treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Metastasis and carcinoma case studies (2 papers). The work is most often cited by research in Surgery (108 citations), Oncology (59 citations) and Urology (11 citations). Neda Hashemi‐Sadraei has collaborated with scholars based in United States and Peru. Frequent co-authors include Nasser H. Hanna, Olumide B. Gbolahan, Bert H. O’Neil, Hristos Z. Kaimakliotis, Chia‐Sui Kao, Rohan Gupta, Modupe Idowu, Carmen M. Perrino, Lei Chen and John N. Eble. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.